Description
Rebuttal to ‘The COMPARZ study presented at ESMO 2012: how pliable is non-inferiority?’
Article: Rebuttal to ‘The COMPARZ study presented at ESMO 2012: how pliable is non-inferiority?’
€2.42
Related products
-
Article: Calendar of events
€2.42 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€2.42 Add to cart -
Article: Highlights in respiratory oncology
€2.42 Add to cart -
Article: Highlights in breast cancer
€2.42 Add to cart
